A Comparison between Misoprostol and Mifepristone plus Misoprostol in the Medical Management of Abortion at a District Hospital of Bangladesh
Kushtia Medical College Journal · 30.06.2025 · 9 (1) · 33-36
DOI: 10.70945/kumc.v09.i01.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kushtia Medical College Journal, online erschienen am 30.06.2025. Verfasst von Mafruha Jahan und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Abortion is a great reproductive health problem worldwide. Despite underlying aetiology or pathology, mainstay of treatment of incomplete abortion is to make the abortion complete – by surgical, medical, or expectant management. Taking medical management of these cases into consideration, this study was planned to compare the efficacy of two different regimens –misoprostol alone Vs misoprostol plus mifepristone in combination.
Methods
This study was conducted from November 2024 to May 2025 at 250 Bedded Mohammad Ali Hospital, Bogura. Total 84 cases were included by purposive sampling technique. Decision of applying misoprostol alone (n=50) or misoprostol plus mifepristone combination (n=29) was taken randomly. Another group (n=5) who already had a course of misoprostol but was unwilling to undergo dilatation and curettage (D&C) at instance, was also given misoprostol plus mifepristone combination. In all three groups, if no good result was achieved, D&C was done. Data was expressed as actual number and percentage of total. In addition, χ2 (Chi Squire) test and Odd’s ratio was used to verify level of significance.
Results
Among the Misoprostol applied cases 30% required D&C. But the cases where Misoprostol plus Mifepristone combination was applied 10% required D&C. The difference was insignificant for χ2 (Chi Squire); but, Odd’s ratio (OR=3.71) was in favour of Misoprostol plus Mifepristone combination. Again, avoiding D&C was possible in 60% of those 5 cases upon whom both the regimen was applied and who were all supposed to undergo D&C.
Conclusion
In conclusion we may say that, as a medical management of incomplete abortion/miscarriage mifepristone plus misoprostol combination is superior to misoprostol alone and can be safely used – a considerable number of D&C can be avoided by this measure.
Zitieren
APA
Jahan, M., Nawrozy, M. S., Sultana, S., & Nesa, H. (2025). A Comparison between Misoprostol and Mifepristone plus Misoprostol in the Medical Management of Abortion at a District Hospital of Bangladesh. Kushtia Medical College Journal, 9(1), 33-36. https://doi.org/10.70945/kumc.v09.i01.13
Vancouver
Jahan M, Nawrozy MS, Sultana S, Nesa H. A Comparison between Misoprostol and Mifepristone plus Misoprostol in the Medical Management of Abortion at a District Hospital of Bangladesh. Kushtia Medical College Journal. 2025;9(1):33-36. doi:10.70945/kumc.v09.i01.13
BibTeX
@article{Jahan2025,
author = {Jahan, Mafruha and Nawrozy, Mst Shaheen and Sultana, Sadia and Nesa, Habiba-Tun},
title = {A Comparison between Misoprostol and Mifepristone plus Misoprostol in the Medical Management of Abortion at a District Hospital of Bangladesh},
journal = {Kushtia Medical College Journal},
year = {2025},
volume = {9},
number = {1},
pages = {33--36},
doi = {10.70945/kumc.v09.i01.13}
}
EUVIMED